Nilotinib Pharmascience 150 mg tvrde kapsule
| Name | Nilotinib Pharmascience 150 mg tvrde kapsule |
|---|---|
| Marketing Authorisation Number | HR-H-811247874 |
| Active Substance | nilotinibklorid dihidrat |
| Composition | jedna tvrda kapsula sadrži 150 mg nilotiniba (u obliku nilotinibklorid dihidrata) |
| Pharmaceutical Form | Kapsula, tvrda |
| Manufacturer | PharOS MT Ltd, Birzebbugia, Malta
Pharos Pharmaceutical Oriented Services Ltd., Metamorfossi Attikis, Grčka |
| Marketing Authorisation Holder | Pharmascience International Limited, Lampousas, 1, Nicosia, Cipar |
| Marketing Authorisation Date | 27.06.2024 |
| MA Period of Validity | 27.06.2029 |
| Classification Number | UP/I-530-09/23-01/100 |
| Registration Number | 381-12-01/70-24-09 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | L01EA03 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
